clelia dispenza - superevent...apr 28, 2017 · dr natascia grimaldi* dr simona todaro* maria di...
TRANSCRIPT
-
Radiation synthesis of nanosized drug delivery devices
CLELIA DISPENZADepartment of Industrial and Digital Innovation
University of Palermo
ITALY
-
MotivationDevelopment of
“MODULAR” NANOCARRIERS
to address the therapeutic needs of specific pathologic states
Drug ProtectionSite Recognition
Triggered ReleaseTracking
Improved biodistribution and pharmacokineticsReduced administered dosesMinimized side-effectsPersonalized therapies
MULTIPLE FUNCTIONS SEVERAL BENEFITS
WITH A SINGLE NANODEVICE
-
NanogelsWater-swollen, crosslinked polymer nanoparticles
• Stable aqueous colloids
• Soft and conformable
• Stimuli-responsive
• MultifunctionalDh= 10 - 100 nm
• Controlled particle size and surface electrical charge
• Reactive groups for conjugation of targeting ligands, drugs, etc.
• Simple production schemes
• Biocompatibility
KEY REQUIREMENTS
-
Radiation synthesis of nanogelsPulsed, e-beam irradiation of semi-diluted aqueous solution of an “inert” polymer.
1. The radiation interacts mainly with water undergoing radiolysis:
2. Water radiolysis products (mainly .OH) react with the polymer, forming polymer radicals:
3. Chemical follow-up reactions lead to the formation of crosslinked polymer nanoparticles
H2O = ∙OH, ∙H, e-aq , HO2∙(O2∙
-)
P+ ∙OH = P∙
-
Radiation synthesis of nanogels
Institute of Nuclear Chemistry and Technology (INCT), Warsaw, Poland.
NO CATALYSTS OR INITIATORS, ORGANIC SOLVENTS AND SURFACTANTS REQUIRED!
Industrial-type
accelerators
(10 MeV)
Doses ≥ Sterilisation
doses Dose per pulse ≈ 10 Gy
Poly(N-vinyl pyrrolidone)
-
Key process parametersC
RO
SSLI
KIN
G
....
.. ..
. ..+
CONTROL OF SIZE and DENSITY
INTRAINTER
PVP NG (0.1) NG (0.2) NG (0.3) NG (0.4) NG (0.5)
Dia
me
tri id
rod
ina
mic
i (n
m)
0
20
40
60
80
100
120
140
160
TEM*
0 50 100 150 200
0,05
0,1
0,25
0,5
Dh, nm
Po
lym
er
con
c., w
t% High dose
per pulse
Low doseper pulse
Poly-N-vinyl pyrrolidone nanogels
non irradiated
DLS 40 kGy
*
error bars = width of size distribution
macro
Polymer concentration and dose per pulse
-
Key process parametersC
RO
SSLI
KIN
G
....
.. ..
. ..+
CONTROL OF SIZE and DENSITY
INTRAINTER
Polymer concentration and dose per pulse
Gel Filtration Chromatography
• Linear polydisperse polymers transform into monodispersenanoparticles;
• Size is insensitive to dose in the 20-80 kGy range.
-
Can the combination between primary radicals be neglected?
OH +OH = H2O2
If the combination between primary radicals cannot be neglected, then…
OH +OH = H2O2
H2O2 +OH = H2O + HO2
2 HO2 = H2O2 + O2
P + O2 = POO …
Key process parameters
-
Pulse length of 50 ns and frequency of 25 Hz for N2O saturated water and aqueous solutions containing PVP and terbutanol.
H2O2 formation
0.05%
Dispenza et al. RSC Adv., 2016, 6, 2582
-
Chemical functionality
0.1 % wt
0.5 % wt
N O HN O
O
OH
HNO
O
OH
NH2
NG-COOH determined by their ability to extract Ni2+ from water NG-NH2 titrated by reaction with fluorescamine
COOH
NH2
NH2
OH
COO-
COOH
COOH
OH
OH
Sabatino et al. Polymer , 2013, vol. 54, 54-64Dispenza et al. RSC Adv., 2016, 6, 2582
Dose-dependant functionalisation
Branching
…
-
CONTROL OF (SURFACE) CHEMISTRY AND TOPOLOGY
....
...
. +
GR
AFT
ING
functional acrylic monomer (e.g. acrylic acid)
(from water radiolysis).
..... .
.. + H2O2/O2
OX
IDA
TIO
N
…COOH
NH2
NH2
OH
COO-
COOH
COOH
OH
OH
CR
OSS
LIK
ING
....
.. ..
. ..+
CONTROL OF SIZE and DENSITY
INTRAINTER
Polymer concentration and dose per pulse
Polymer concentration, dose per pulse and dose
Key process parameters
Polymer concentration, dose per pulse and dose, reactive solutes
-
From nanogel to nanodevice
COOH
COOH
NH2
COO-
NH2
COOHNH2
COO-
COO-
COOH
COOHCOOH
OH
COOH
PVP-co-AA 40kGy
z-potential = -25 mVDh = 70 nm PDI = 0.25
-
ANTIBODIES
Targeting
Ligands
PEPTIDES
COOH
COOH
NH2
COO-
NH2
COOHNH2
COO-
COO-
COOH
COOHCOOH
OH
COOH
From nanogel to nanodevice
-
ANTIBODIES
NUCLEIC ACIDS
Targeting
Ligands
Therapeutics
-DOXO-S-S-
CHEMOTHERAPEUTICS
PROTEINS
PEPTIDES
COOH
COOH
NH2
COO-
NH2
COOHNH2
COO-
COO-
COOH
COOHCOOH
OH
COOH
From nanogel to nanodevice
-
ANTIBODIES
NUCLEIC ACIDS
Targeting
Ligands
Therapeutics
-DOXO-S-S-
CHEMOTHERAPEUTICS
PEPTIDES
COOH
COOH
NH2
COO-
NH2
COOHNH2
COO-
COO-
COOH
COOHCOOH
OH
COOH DOTA-[Lys3]BBN
CHELATING AGENTS
Diagnostic
tools
PROTEINS
From nanogel to nanodevice
-
-DOXO-S-S-
COOH
COOH
NH2
COO-
NH2
COOHNH2
COO-
COO-
COOH
COOHCOOH
OH
COOH DOTA-[Lys3]BBN
conjugation through amide bond(EDC, Sulfo-NHS)
FITC, AminoFluo
TRITC, amino-Atto633
Fluo. probe
From nanogel to nanodevice
-
-DOXO-S-S-
COOH
COOH
NH2
COO-
NH2
COOHNH2
COO-
COO-
COOH
COOHCOOH
OH
COOH DOTA-[Lys3]BBN
Insulin
1. Biomacromolecules (2012) 13, 1805-1817.2. J. Appl. Polym. Sci (2014) 131(2), 39774-39782.3. Biomaterials (2016) vol. 80, 179-194.4. Molecules (2017) vol 21(11),1594.5. Biological Chemistry (2017) vol. 398(2), pp. 277-287.
[5]
[2, 5] [4]
[4]
[1,3]
From nanogel to nanodevice
-
Insulin has important effects in the treatment of neurological diseases, such as Alzheimer’s Disease (AD) for the recovery of memory deficit.
Alzheimer’s disease
Insulinresistance
Insulinin CNS
AD is also named Type III diabetes
HealthyAdvancedAlzheimer’s
The ProblemEfficient delivery of insulin to the central nervous system is hampered by the Blood Brain Barrier.
Enhanced nose-to-brain insulin delivery through nanogel carriers
-
Enhanced nose-to-brain insulin delivery through nanogel carriers
Alzheimer’s disease
Insulinresistance
Insulinin CNS
AD is also named Type III diabetes
HealthyAdvancedAlzheimer’s
The StrategyIntranasal delivery: the delivery occurs mainly by the olfactory and trigeminal nerve pathways.
Insulin has important effects in the treatment of neurological diseases, such as Alzheimer’s Disease (AD) for the recovery of memory deficit.
-
INTRANASAL DELIVERY LIMITATIONS
• Small sprayed volumes
• Low permeability of nasal mucosa
• Hormone degradation by protolithic enzymes
• Harmful effects on the nasal epithelium
Enhanced nose-to-brain insulin delivery through nanogel carriers
-
NG-In biological evaluation
NG-Atto633
NG-In
NG-InFITC
NG-Atto633 -InFITC
PVP-co-AA NGe-beam irradiation
(40 kGy)
-
NG-In biological evaluation
URINE ANALISYS
BIODISTRIBUTION
NG in blood
-
NG-In biological evaluation
No deterioration of NASAL MUCOSA
before after 10 min after 30 min
BRAIN DISTRIBUTION
Free InsulinFITC NG-InFITC
NGs cross NASAL MUCOSA
No brain immunogenic response.
-
HYPPOCAMPUS CORTEX
• Radiation engineered NANOGELS are versatile, biocompatible NANOCARRIERS.
• NG-In is MUCOADHESIVE and RESISTANT TO PROTEOLYTIC ENZYMES.
• NG-In carries biologically active insulin to the brain with higher efficiency.
• NG-In can be cleared from blood and organs (where do not induce modifications).
• Repeated administration effects and studies of disease models are undergoing.
INSULIN SIGNALINGACTIVATION
NG-In biological evaluation
-
DIPARTIMENTO DELL’INNOVAZIONEINDUSTRIALE E DIGITALE (UniPa-Italy) Prof. Giuseppe SpadaroProf. Sabina AlessiDr Maria Antonietta SabatinoDr Natascia Grimaldi*Dr Simona Todaro*Maria Di Filippo, PhD studentLorena Anna Ditta, PhD studentAlessia Ajovalasit, PhD student
ISTITUTO DI BIOLOGIA MOLECOLARE (CNR-Italy)Dr Marta Di CarloDr Pasquale PiconeDr Domenico Nuzzo
ISTITUTO DI BIOFISICA(CNR-Italy)Dr Donatella BuloneDr Daniela GiacomazzaDr Pier Luigi San Biagio
ROYAL INSTITUTE OF TECHNOLOGY(Stockholm, Sweden) Prof. Mats Jonsson
INSTITUTE OF NUCLEAR CHEMISTRY AND TECHNOLOGY (Warsaw, Poland)Dr. Grazyna PrzybytniakDr. Marta WaloProf. Andrzej Chmielewski
€
UNIVERSITY OF MARYLAND(College Park, MD, USA)Prof. Mohamad Al-Sheikhly
*past PhD student
STEBICEF (UniPa-Italy)Prof. Antonella Amato Prof. Flavia Mulè
Acknowledgments
NG-In team
PRIN project “NANOMED”
IAEA CRP 2014- 2018 on “Nanosized Delivery Systems for Radiopharmaceuticals.”
IAEA CRP 2009- 2012 on "Nanoscale Radiation Engineering for Biomedical Applications”.
PON HIPPOCRATES
-
THANK YOU FOR YOUR ATTENTION!
Please, join us for the
organised in collaboration with IAEA